Abstract
ObjectivesAntimicrobial-resistantNeisseria gonorrhoeae(NG) is a concern. Little is known about antimicrobial susceptibility profiles and associated genetic resistance mechanisms of NG in Madagascar. We report susceptibility data of NG isolates obtained by the medical laboratory (CBC) of the Institut Pasteur de Madagascar, Antananarivo, Madagascar, during 2014–2020. We present antimicrobial resistance mechanisms data and phenotype profiles of a subset of isolates.MethodsWe retrieved retrospective data (N=395) from patients with NG isolated during 2014−2020 by the CBC. We retested 46 viable isolates including 6 found ceftriaxone and 2 azithromycin resistant, as well as 33 isolated from 2020. We determined minimal inhibitory concentrations for ceftriaxone, ciprofloxacin, azithromycin, penicillin, tetracycline and spectinomycin using Etest. We obtained whole-genome sequences and identified the gene determinants associated with antimicrobial resistance and the sequence types (STs).ResultsOver the study period, ceftriaxone-resistant isolates exceeded the threshold of 5% in 2017 (7.4% (4 of 54)) and 2020 (7.1% (3 of 42)). All retested isolates were found susceptible to ceftriaxone, azithromycin and spectinomycin, and resistant to ciprofloxacin. The majority were resistant to penicillin (83% (38 of 46)) and tetracycline (87% (40 of 46)). We detected chromosomal mutations associated with antibiotic resistance ingyrA, parC, penA, ponA,porBandmtrRgenes. None of the retested isolates carried the mosaicpenAgene. The high rate of resistance to penicillin and tetracycline is explained by the presence ofblaTEM(94.7% (36 of 38)) andtetM(97.5% (39 of 40)). We found a high number of circulating multilocus STs. Almost half of them were new types, and one new type was among the four most predominant.ConclusionsOur report provides a detailed dataset obtained through phenotypical and genotypical methods which will serve as a baseline for future surveillance of NG. We could not confirm the occurrence of ceftriaxone-resistant isolates. Our results highlight the importance of implementing quality-assured gonococcal antimicrobial resistance surveillance in Madagascar.
Funder
Department of Health and Social Care’s Fleming Fund using UK aid
Subject
Infectious Diseases,Dermatology
Reference40 articles.
1. WHO . Antibiotic-resistant gonorrhoea on the rise, new drugs needed, . 2017 Available: https://www.who.int/news/item/07-07-2017-antibiotic-resistant-gonorrhoea-on-the-rise-new-drugs-needed [Accessed 7 Dec 2022].
2. WHO . Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae, . 2012 Available: http://apps.who.int/iris/bitstream/10665/44863/1/9789241503501_eng.pdf [Accessed 7 Dec 2022].
3. Centers for Disease Prevention and Control . U.S. Department of Health and Human Services Atlanta, GA; Antibiotic Resistance Threats in the United States, . 2019 Available: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
4. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
5. Cehovin A , Lewis SB . Mobile genetic elements in Neisseria Gonorrhoeae: movement for change. Pathog Dis 2017;75. doi:10.1093/femspd/ftx071